Matteo Bovolenta

Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions.

A new dystrophin-deficient rat model mirroring exon skipping in patients with DMD exon 45 deletions.

Journal: Disease models & mechanisms

Published: July 22, 2025

In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment.

In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment.

Journal: Pharmaceutics

Published: July 04, 2024

Correction of exon 2, exon 2-9 and exons 8-9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system.

Correction of exon 2, exon 2-9 and exons 8-9 duplications in DMD patient myogenic cells by a single CRISPR/Cas9 system.

Journal: Scientific reports

Published: January 30, 2024

Antisense Oligonucleotides Conjugated with Lipophilic Compounds: Synthesis and In Vitro Evaluation of Exon Skipping in Duchenne Muscular Dystrophy.

Antisense Oligonucleotides Conjugated with Lipophilic Compounds: Synthesis and In Vitro Evaluation of Exon Skipping in Duchenne Muscular Dystrophy.

Journal: International journal of molecular sciences

Published: March 16, 2022

Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach.

Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach.

Journal: Molecules (Basel, Switzerland)

Published: November 11, 2021

Corrigendum to: "Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression". [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138-1147.].

Corrigendum to: "Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression". [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138-1147.].

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: November 04, 2020

A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients.

A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients.

Journal: Cell reports

Published: August 24, 2020

Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts.

Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: January 03, 2019

C6orf10 Low-Frequency and Rare Variants in Italian Multiple Sclerosis Patients.

C6orf10 Low-Frequency and Rare Variants in Italian Multiple Sclerosis Patients.

Journal: Frontiers in genetics

Published: October 30, 2018

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.

Journal: Molecular therapy. Nucleic acids

Published: March 02, 2018

Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.

Transcriptional and epigenetic analyses of the DMD locus reveal novel cis‑acting DNA elements that govern muscle dystrophin expression.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: May 09, 2017

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.

Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.

Journal: Molecular therapy. Nucleic acids

Published: November 12, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026